Sylwia Marshall

Sylwia Marshall is the VP of Translational Sciences at invoX Pharma, with a background in leading pre-clinical safety assessment and DMPK activities for bi-specific immuno-oncology therapeutics. Prior to that, Sylwia held senior positions at F-star Therapeutics, Inc., Envigo +++, Huntingdon Life Sciences, and Novartis, where Sylwia was involved in various aspects of biopharmaceutical development. Sylwia's educational background includes a PhD in Cell Biology from The University of Manchester and a BSc Hons in Biomedical Sciences from the University of Durham.